21052 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors Angiotensin converting enzyme inhibitors
THERAPEUTIC USES OF DULAGLUTIDE
#2METHOD OF TREATING DRUG RESISTANT HYPERTENSION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION BY COMBINED DRUG TREATMENT WITH BAROPACING AND BETA BLOCKERS
#3PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM
#4Opthalmic Compositions for Treating Coronaviruses
#5Micronutrient combination to reduce blood pressure
#6Compositions and methods for treating COVID-19
#7Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
#8THERAPEUTIC USES OF DULAGLUTIDE
#9Celocoxib Binding Antibodies and Uses Thereof
#10METHODS FOR TREATING CANCERS USING ACE INHIBITORS, ARB, OR CELECOXIB AND OLMESARTAN
#11Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency
#12Celocoxib Binding Antibodies and Uses Thereof
#13Application of dipeptide as ace enzyme activity inhibitor
#14NEUREGULIN BASED METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES
#15Methods For Treating Cancers Using Ace Inhibitors, ARB, or Celecoxib and Olmesartan
#16Celocoxib Binding Antibodies and Uses Thereof
#17Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#18Composition for the treatment of progressive renal diseases
#19Use of the angiotensin-(1-9) peptide or derivatives thereof, use of vectors overexpressing the ACE2 enzyme that produces angiotensin-(1-9) for preparing medicaments useful for preventing, reverting, inhibiting and/or reducing hypertension and/or inducing vasodilation
#20Neuregulin based methods and compositions for treating cardiovascular diseases
#21Factor XII inhibitors for the treatment of neurological inflammatory disorders
#22Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#23Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
#24Peptides and use thereof in the inhibition of angiotensin converting enzyme
#25METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#26LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
#27PREVENTION OF THROMBUS FORMATION AND/OR STABILIZATION
#28ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF PERINDOPRIL
#29COMPOSITIONS AND METHODS FOR TREATMENT OF BODY WEIGHT CONDITIONS
#30Inhalable Formulations For Treating Pulmonary Hypertension And Methods Of Using Same
#31METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#32Use of S1P Receptor Agonists in Heart Diseases
#33Neuregulin based methods and compositions for treating cardiovascular disease
#34METHODS OF TREATMENT FOR PULMONARY FIBROSIS
#35Diabetic nephropathy therapies
#36Orodispersible pharmaceutical composition of perindopril
#37Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications
#38Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency
#39METHODS OF DIAGNOSIS AND TREATMENT FOR METABOLIC DISORDERS
#40METHODS AND COMPOSITIONS FOR TREATING CONGESTIVE HEART FAILURE
#41ANTIMICROBIAL PEPTIDES AND BACTERIAL STRAINS THAT PRODUCE THEM
#42Treatment of Prevention of Unscheduled Bleeding in Women on Progestogen Containing Medication
#43Peptide inhibiting angiotensin converting enzyme
#44Treatment for Organ Regeneration with Combination of Drug and Biologics
#45Compositions comprising tripeptides inhibiting ace
#46LIPOSOMAL REDUCED GLUTATHIONE AND 1-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
#47Use of S1P receptor agonists in heart diseases
#48Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII
#49STABLE FORMULATIONS OF ACE INHIBITORS, AND METHODS FOR PREPARATION THEREOF
#50Methods for treating conditions associated with the accumulation of excess extracellular matrix
#51Enhanced drug delivery in transdermal systems
#52Enhanced drug delivery in transdermal systems
#53Use of Inhibitors of the Renin-Angiotensin System for the Treatment of Lung Injuries
#54Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme Inhibitors
#55METHODS AND COMPOSITIONS FOR REDUCING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH THE ADMINISTRATION OF ARTIFICIAL BLOOD
#56Biocompatible stent
#57STEM CELL THERAPY FOR CARDIAC VALVULAR DYSFUNCTION
#58COMPOSITIONS AND METHODS FOR ENHANCING VASODILATION
#59ILK inhibitors for the treatment of renal disease
#60Combined use of enzyme inhibitors and of pharmaceutical compositions thereof
#61Use of nitric oxide adducts
#62Compounds that inhibit caspase activity for treating glaucoma
#63Dairy components effective for fat loss
#64Combined use of a GLP-1 compound and a modulator of diabetic late complications
#65Thio-containing inhibitors of aminopeptidase P, and compositions thereof
#66Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
#67Methods and compositions for treating congestive heart failure
#68Inhalable formulations for treating pulmonary hypertension and methods of using same
#69Process for the preparation of angiotensis converting enzyme (ACE) inhibitors and its use
#70Compositions and methods for treatment of body weight conditions
#71Combination therapy for diabetes, obesity and cardiovascular diseases using GDF-8 inhibitors
#72Neuregulin based methods and compositions for treating cardiovascular diseases
#73Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
#74Use of s1p receptor agonists in heart diseases
#75Diabetic nephropathy therapies
#76Stable pharmaceutical compositions comprising ace inhibitor(s)
#77Methods for treating conditions associated with the accumulation of excess extracellular matrix
#78Ilk inhibitors for the treatment of renal disease
#79Orodispersible pharmaceutical composition comprising perindopril
#80Compositions and methods for treatment of body weight conditions
#81Method of reducing type 2 diabetes in high risk patients
#82Methods for treating conditions associated with the accumulation of excess extracellular matrix
#83Method for the continuous production and coating of self-adhesive compounds on the basis of SBC that includes at least one pharmaceutically active substance
#84ENZYMATIC TREATMENT OF WHEY PROTEINS FOR THE PRODUCTION OF ANTIHYPERTENSIVE PEPTIDES, THE RESULTING PRODUCTS AND TREATMENT OF HYPERTENSION IN MAMMALS
#85Micronutrient combination to reduce blood pressure